Systemic Therapy for Metastatic Colorectal Cancer

Sequencing therapy in the metastatic setting is challenging and requires that clinicians consider overlapping mechanisms of action and toxicity profiles when selecting among agents.  Clinicians need to be aware of the new data, new FDA approvals, and new changes in the guideline recommendations for metastatic colorectal cancer in order to choose appropriate systemic therapies, which is critical to ensure optimal treatment of patients.

Target Audience

This educational activity is designed to meet the needs of physicians, nurses, pharmacists, and other clinical professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Discuss new data on metastatic colorectal cancer, particularly as it relates to the NCCN Guidelines for Colon and Rectal Cancer
Additional information
Supporters: 

Supported by an educational grant from Genentech, USA.

Course summary
Available credit: 
  • 0.25 Participation
  • 0.33 Nurse
  • 0.25 Pharmacist
  • 0.25 Physician
Course opens: 
08/09/2013
Course expires: 
03/01/2014
Cost:
$0.00

Leonard Saltz, MD
Memorial Sloan-Kettering Cancer Center

Available Credit

  • 0.25 Participation
  • 0.33 Nurse
  • 0.25 Pharmacist
  • 0.25 Physician

Accreditation Period

Course opens: 
08/09/2013
Course expires: 
03/01/2014

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

To access this activity, users will need:

  • A device with an Internet connection and sound playback capability
  • Adobe Flash Player and/or an HTML5 capable browser for video and audio playback
  • Adobe Reader for certificate viewing/printing